Results 11 to 20 of about 18,078 (213)

Differential Modulation of Serum Albumin and Butyrylcholinesterase Following Pemafibrate Treatment in MASLD: A Post Hoc Analysis of the PEMA-FL Trial [PDF]

open access: yesMetabolites
Background: Pemafibrate, a selective peroxisome proliferator-activated receptor-α (PPARα) modulator, improves liver stiffness and biochemistry in metabolic dysfunction-associated steatotic liver disease (MASLD).
Ryohei Tanigawa   +6 more
doaj   +2 more sources

Cord Blood Butyrylcholinesterase Activities in Normal Pregnant and Preeclamptic Women

open access: yesAvicenna Journal of Medical Biochemistry, 2016
Background Human placenta, a non-neural tissue, contains cholinergic system and high-affinity muscarinic receptors. The role of cholinesterases (CE) in trophoblast function and pregnancy is not clear. Objectives
Kharb   +5 more
doaj   +2 more sources

Benzoylcholine, Indole-3-acetic And Human Serum Butyrylcholinesterase Interactions [PDF]

open access: yesTürk Biyokimya Dergisi, 2006
In this study we studied the kinetic interaction of indole-3- acetic acid with human serum butyrylcholinesterase. Butyrylcholinesterase was purified from human serum and the benzoylcholine kinetics was analyzed.
Ebru Bodur,, A. Neşe Çokuğraş
doaj   +1 more source

The Selectivity of Butyrylcholinesterase Inhibitors Revisited

open access: yesMolecules
Acetylcholinesterase (AChE) inhibitors are the primary target for single-molecule anti-Alzheimer’s disease (AD) therapeutics. Though AChE has historically been the focus of investigation for small-molecule inhibitors, interest in another cholinergic ...
Michael D. Gambardella   +2 more
doaj   +4 more sources

Design, Synthesis, and Biological Evaluation of Molecular Hybrids Incorporating Coumarin-Pyrazole-Linked Indolinone Derivatives With Antioxidant and Anti-Alzheimer Properties. [PDF]

open access: yesChem Biodivers
ABSTRACT The increase in global life expectancy has resulted in a significant rise in the occurrence of Alzheimer's disease (AD), making it a critical public health burden. Therefore, there is an urgent need to create effective methods to prevent or slow down the progression of the disease.
Sabt A   +6 more
europepmc   +2 more sources

The role of acetylcholinesterase and butyrylcholinesterase activity in the development of delirium in acute stroke

open access: yesCerebral Circulation - Cognition and Behavior, 2021
Aim: Our study aimed to test whether plasma acetylcholinesterase and butyrylcholinesterase enzyme activity were related to the presence and intensity of delirium in acute stroke patients.
Lara Caeiro   +5 more
doaj   +1 more source

Biologically Potent Benzimidazole-Based-Substituted Benzaldehyde Derivatives as Potent Inhibitors for Alzheimer’s Disease along with Molecular Docking Study

open access: yesPharmaceuticals, 2023
Twenty-one analogs were synthesized based on benzimidazole, incorporating a substituted benzaldehyde moiety (1–21). These were then screened for their acetylcholinesterase and butyrylcholinesterase inhibition profiles.
Bushra Adalat   +11 more
doaj   +1 more source

Pseudo-irreversible butyrylcholinesterase inhibitors: structure–activity relationships, and kinetic, computational, and crystallographic study of the N-dialkyl O-arylcarbamate warhead [PDF]

open access: yes, 2022
Alongside reversible butyrylcholinesterase inhibitors, a plethora of covalent butyrylcholinesterase inhibitors have been reported in the literature, typically pseudo-irreversible carbamates. For these latter, however, most cases lack full confirmation of
Anže , Meden   +10 more
core   +2 more sources

Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment

open access: yes, 2005
The most successful approach for treating people with Alzheimer's disease to date has been by improving cholinergic transmission using cholinesterase inhibitors.
Ballard, C G, Tasker, A, Perry, E K
core   +5 more sources

Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase. [PDF]

open access: yesPLoS ONE, 2013
Concerns about the safety of paralytics such as succinylcholine to facilitate endotracheal intubation limit their use in prehospital and emergency department settings.
Brian C Geyer   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy